表 1.
日本JCOG0804、JCOG1211、JCOG0802临床研究总结
Summary of clinical studies of JCOG0804, JCOG1211 and JCOG0802 in Japan
| Project name | Inclusion criteria | Surgical method | Lymph node dissection | 5-yr RFS | 5-yr OS | Local recurrence | Recommended method |
| T: maximum tumor diameter; CTR: consolidation tumor ratio; RFS: relapse-free survival; OS: overall survival. | |||||||
| JCOG 0804 | T≤2 cm and CTR≤0.25 | Segmentectomy/edge resections | Not mandatory | 99.7% | 99.7% | No | Segmentectomy/ wedge resections |
| JCOG 1211 | (2 cm＜T≤3 cm，and CTR≤0.5)/ (T≤2 cm and 0.25＜CTR≤0.5) | Segmentectomy | Hilar, interlobar and intrapulmonary | 98% | 98% | - | - |
| JCOG 0802 | T≤2.0 cm and CTR＞0.5 | Segmentectomy/Lobectomy | Hilar and mediastinal | Segmentectomy vs Lobectomy: 88% vs 87.9% | Segmentectomy vs Lobectomy: 94.3% vs 91.1% | Segmentectomy vs Lobectomy: 10.5% vs 5.4% | Segmentectomy |